Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (Nasdaq I TSX: TLRY), a global pioneer in medical cannabis research, cultivation, and production, today announced the launch of medical cannabis edibles in THC and CBD-rich varieties of chocolates and soft chew gummies. The new Tilray-branded medical cannabis edibles are now available for patients across Canada and add to the brand's comprehensive offering of cannabis medicines, including whole flower, oils, vapes, and pre

Tilray Launches New Medical Cannabis Edibles in Canada

Clean Energy Fuels

Clover Health Investments

Lucid Group

Wish

Workhorse Group

Exela Technologies

If the "meme stocks" trend is here to stay, names popular with the r/WallStreetBets community could change over time. These seven Reddit stocks could have the potential to rebound to their prior highs in the coming months.

7 Reddit Stocks To Buy if The ‘Meme Stocks' Trend Has Runway

The cannabis company's growth forecasts may be a bit too optimistic.

Can Tilray Really More Than Quadruple Its Annual Revenue by 2024?

TLRY stock should be worth $19.18 assuming the company meets its likely 15% target for free cash flow margin, and the analysts agree. The post Tilray Is Finally Making Money, So Expect Its Stock to Go Up in Price appeared first on InvestorPlace.

Tilray Is Finally Making Money, So Expect Its Stock to Go Up in Price

TLRY stock seems positioned for further rally with strong growth and positive industry tailwinds. Global expansion to accelerate growth.

Tilray Stock Looks Positioned For Further Rally After A Strong Quarter

SweetWater Brewing Company, LLC, has ventured into the state of Michigan just weeks following the launch of a new, full-service brewery, production facility, taproom and restaurant in Colorado. The Atlanta, Georgia-based company announced Wednesday that Michigan beer lovers can now enjoy its core line of brews, including its flagship 420 Extra Pale Ale, its juicy HAZY IPA, SweetWater Oasis Premium Hard Seltzer and its recently launched 420 Imperial IPA.

Tilray's SweetWater Brewing Co. Announces Expansion Across Michigan, Beer Lovers Delighted

Aurora Cannabis

Canopy Growth

Cronos Group

There are major risks associated with the consumption of large amounts of cannabis by young children. Unlike in adults, the risks to children include coma and even death if the child is so profoundly sedated that they cannot protect their airway.

The Underappreciated Risk Of Pediatric Cannabis Overdose

Investors can finally see the first rays of sunlight after a terrible year for this pot grower.

Is Tilray the Ultimate Turnaround Marijuana Stock of 2021?

It may remain volatile for now. But in the long-run, TLRY stock could climb to levels far above where it trades today (around $17 per share).

Tilray Stock Is Worth Buying and Holding If You Have a Little Patience

A viable cannabis company is going to need distribution into the US or Europe or other markets to be a viable long-term company. The post Tilray Stock Makes Profit, Crowd Goes Wild!

Tilray Stock Makes Profit, Crowd Goes Wild!

Canadian cannabis stocks took a beating In July, with the Canadian Cannabis LP Index posting a 9.8% loss while continuing the declining streak, which was slightly interrupted by a 1% gain in June. The index, which saw a 30.1% drop in 2020, grew 13.6% over the past year.

Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July

As the bears go into hibernation, TLRY stock is on a well-deserved but nonetheless shocking journey to much higher price points. The post In Light of Surprise Profit, Tilray Is a Cannabis Go-To Holding appeared first on InvestorPlace.

In Light of Surprise Profit, Tilray Is a Cannabis Go-To Holding

Will These Become Favorites On Robinhood And Reddit In August? The post Are These The Best Marijuana Stocks On Robinhood? 3 Top Pot Stocks On The Nasdaq appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Marijuana Stocks On Robinhood? 3 Top Pot Stocks On The Nasdaq

Tilray is losing exposure on WallStreetBets. Is that a bad thing for TLRY stock?

Tilray Stock Is Still a Great Bet on Legalization If You Have the Patience

Innovative Industrial Properties

Trulieve Cannabis Corp.

Here's the Best Cannabis Stock to Buy in August

AMC Entertainment

Alibaba

Carnival

AMC, Tilray, Carnival, Alibaba, Apple, Facebook — Stocks New Jersey Pension Fund Bought And Sold In Q2

These marijuana companies are entering new markets and making more money than ever before.

3 Cannabis Growth Stocks You Don't Want to Miss in August

New Jersey's embattled pension initiated a position in AMC Entertainment, increased investments in marijuana stock Tilray and cruise giant Carnival, and slashed its stake in Alibaba.

A Giant Fund Scooped Up AMC Stock, Bought More Tilray and Carnival

Behold that rarest of all animals on the exchange -- a profitable cannabis company!

Why Tilray Is Trouncing the Market This Week

Clever Leaves Holdings Inc

Grove

GrowGeneration Corp

High Tide

IM Cannabis Corp

Coffee Holding

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

10 Cannabis Stocks That Ran Extra Hot This Week

CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (Nasdaq: HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide.

High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ ) and Results of Annual General Meeting

Tilray posted an unexpected profit in Q4. However, there's more to the story.

Is Tilray Stock a Buy After Its Surprising Q4 Profit?

HEXO Corp

OrganiGram Holdings Inc.

SNDL Inc.

The Senate's marijuana legalization bill "will not pass."

Why Hexo, Tilray, OrganiGram, and Sundial Stocks Are Wilting

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) confirmed Thursday it has summoned and postponed its long-anticipated special meeting of shareholders, at which stockholders were meant to vote on two important proposals – 1) Share dilution and 2) Several governance changes with the purpose of increasing stockholders rights. The special meeting was adjourned until August 19.

Tilray Postpones Special Meeting To Solicit Proxies, Says Majority Of Shareholders Support Dilution And Other Proposals

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today convened and then adjourned the Special Meeting of Stockholders intended to approve two shareholder proposals: (1) a proposal to increase the authorized number of shares of common stock (“Authorized Shares Proposal”); and (2) a number of governance enhancements to increase stockholder rights (the “Governanc

Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021

News for Tilray Brands Stock (TLRY)